Occurrence of hepatic veno-occlusive disease (VOD) has been reported in up to 60% of
patients following stem cell transplantation (SCT). However, the incidence varies widely …

Hepatic veno-occlusive disease (VOD) is the most common of the regimen-related toxicities
accompanying stem cell transplantation (SCT). Despite aggressive therapies, including the …

In contrast to the upfront setting in which the role of high-dose therapy with autologous
hematopoietic cell transplantation (HCT) as consolidation of a first remission in patients with …

Background Teclistamab is a T-cell–redirecting bispecific antibody that targets both CD3
expressed on the surface of T cells and B-cell maturation antigen expressed on the surface …

Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly
understood. Here we report the massively parallel sequencing of 38 tumour genomes and …

Background G protein–coupled receptor, family C, group 5, member D (GPRC5D) is an
orphan receptor expressed in malignant plasma cells. Talquetamab, a bispecific antibody …

We performed massively parallel sequencing of paired tumor/normal samples from 203
multiple myeloma (MM) patients and identified significantly mutated genes and copy number …

Background New treatment options are needed for patients with multiple myeloma that is
refractory to proteasome inhibitors and immunomodulatory drugs. We assessed …

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell
Lymphoma Page 1 Multicenter Phase II Study of Bortezomib in Patients With Relapsed or …

AIDS patients who develop lymphoma are often treated with transplanted hematopoietic
progenitor cells. As a first step in developing a hematopoietic cell–based gene therapy …